Concepts (55)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microsomes, Liver | 4 | 2010 | 69 | 0.220 |
Why?
|
| Morpholines | 3 | 2010 | 65 | 0.210 |
Why?
|
| Receptor, Cannabinoid, CB2 | 2 | 2010 | 33 | 0.160 |
Why?
|
| Sterols | 1 | 2016 | 22 | 0.150 |
Why?
|
| Boronic Acids | 1 | 2016 | 19 | 0.150 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2016 | 28 | 0.140 |
Why?
|
| Indoles | 2 | 2006 | 154 | 0.120 |
Why?
|
| Endocrine Disruptors | 1 | 2012 | 38 | 0.100 |
Why?
|
| Indomethacin | 1 | 2010 | 24 | 0.100 |
Why?
|
| Water Pollutants, Chemical | 1 | 2012 | 158 | 0.090 |
Why?
|
| Receptors, Cannabinoid | 2 | 2004 | 26 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2010 | 406 | 0.060 |
Why?
|
| Piperidines | 1 | 2004 | 76 | 0.060 |
Why?
|
| Pyrazoles | 1 | 2004 | 80 | 0.060 |
Why?
|
| Naphthalenes | 1 | 2002 | 37 | 0.060 |
Why?
|
| Receptors, Drug | 1 | 2002 | 56 | 0.050 |
Why?
|
| Cannabinoids | 1 | 2002 | 54 | 0.050 |
Why?
|
| Liver | 1 | 2004 | 447 | 0.050 |
Why?
|
| Rats | 4 | 2010 | 3261 | 0.040 |
Why?
|
| Biological Availability | 1 | 2016 | 84 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2016 | 61 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 2016 | 162 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2016 | 212 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2016 | 105 | 0.030 |
Why?
|
| Animals | 5 | 2016 | 14307 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 209 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 420 | 0.030 |
Why?
|
| Mass Spectrometry | 2 | 2006 | 255 | 0.030 |
Why?
|
| Molecular Structure | 2 | 2006 | 467 | 0.030 |
Why?
|
| New Orleans | 1 | 2012 | 11 | 0.030 |
Why?
|
| Ethinyl Estradiol | 1 | 2012 | 9 | 0.030 |
Why?
|
| Water Pollution, Chemical | 1 | 2012 | 10 | 0.030 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2012 | 17 | 0.030 |
Why?
|
| Geologic Sediments | 1 | 2012 | 41 | 0.030 |
Why?
|
| Fresh Water | 1 | 2012 | 47 | 0.030 |
Why?
|
| Seawater | 1 | 2012 | 46 | 0.030 |
Why?
|
| Mississippi | 1 | 2012 | 107 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 1530 | 0.030 |
Why?
|
| Pesticides | 1 | 2012 | 44 | 0.030 |
Why?
|
| Benzhydryl Compounds | 1 | 2012 | 42 | 0.030 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2012 | 40 | 0.030 |
Why?
|
| Phenols | 1 | 2012 | 76 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1149 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2010 | 94 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 2128 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 173 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2016 | 1802 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 1426 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 555 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2004 | 281 | 0.010 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 129 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 901 | 0.010 |
Why?
|
| Benzoxazines | 1 | 2002 | 46 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2002 | 376 | 0.010 |
Why?
|
| Female | 1 | 2016 | 19873 | 0.010 |
Why?
|